.AstraZeneca has shared a very early look at the performance of its internal antibody-drug conjugate...
.After announcing a stage 3 launch based upon positive midstage end results, iTeos and also GSK are ...
.The FDA needs to be more available and also collective to let loose a surge in commendations of rar...
.It's an unusually active Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara R...
.Atea Pharmaceuticals' antiviral has actually failed another COVID-19 trial, yet the biotech still k...
.Neurocrine Biosciences' schizophrenia plan pivot has fallen short. The biotech was not able to imit...
.Sanofi has actually created an overdue entry to the radioligand gathering, spending 100 million eur...
.After F2G's 1st effort to receive a brand-new course of antifungal to market was derailed due to th...
.Moderna has actually pledged to cut R&D spending by $1.1 billion by 2027. The selection to shrin...
.Only four months after Sanofi bet $80 thousand in beforehand money on Key Therapies' losmapimod, th...